Compare Nestmedic SA with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
24.52%
0%
24.52%
6 Months
20.62%
0%
20.62%
1 Year
22.54%
0%
22.54%
2 Years
8.73%
0%
8.73%
3 Years
-56.87%
0%
-56.87%
4 Years
-59.79%
0%
-59.79%
5 Years
-42.39%
0%
-42.39%
Nestmedic SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.10%
EBIT Growth (5y)
-29.04%
EBIT to Interest (avg)
-4.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.67
Sales to Capital Employed (avg)
0.18
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.82
EV to EBIT
-8.09
EV to EBITDA
-10.33
EV to Capital Employed
4.23
EV to Sales
30.48
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-52.30%
ROE (Latest)
-45.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
0.20
0.20
Operating Profit (PBDIT) excl Other Income
-0.50
-0.80
37.50%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.70
-1.00
30.00%
Operating Profit Margin (Excl OI)
-3,134.00%
-4,937.90%
180.39%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 0.00% vs -50.00% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 30.00% vs 9.09% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
0.80
1.00
-20.00%
Operating Profit (PBDIT) excl Other Income
-3.40
-4.20
19.05%
Interest
0.40
0.30
33.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.60
-5.40
14.81%
Operating Profit Margin (Excl OI)
-5,082.30%
-5,419.70%
33.74%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -20.00% vs -33.33% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 14.81% vs 20.59% in Dec 2024
About Nestmedic SA 
Nestmedic SA
Software Products
Nestmedic SA is a Poland-based company engaged in the manufacture of medical diagnostic equipment. The Company focuses on the development and production of a telemedicine cardiotocography (CTG) device for fetal health monitoring, named Pregnabit. The Pregnabit solution comprises the display device; fetal heart rate (FHR) probe; wrist heart rate monitor, which measures mother’s pulse; tocodynamometer (toco) probe, which measures contractions of the uterus, as well as fetal movement marker. Pregnabit enables pregnant women to take CTG tests at home, without specialist's assistance. The results are sent wirelessly to Medical Telemonitoring Center (MTC) where medical consultant analyzes data and provides medical opinion.
Company Coordinates 
Company Details
Ul. Krakowska 141-155 , WROCLAW None : 50-428
Registrar Details






